| Bimagrumab vs optimized standard of care for treatment of sarcopenia in community-dwelling older adults: a randomized clinical trial D Rooks, T Swan, B Goswami, LA Filosa, O Bunte, N Panchaud, ... JAMA network open 3 (10), e2020836-e2020836, 2020 | 119 | 2020 |
| A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquine FJ Leong, JP Jain, Y Feng, B Goswami, DS Stein Malaria journal 17, 1-11, 2018 | 26 | 2018 |
| ESTIMATION OF LONG‐TERM SURVIVAL WITH TAFASITAMAB+ LENALIDOMIDE (LEN) IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL) G Salles, B Goswami, V Bagnardi, D Dey, M Winderlich, S Ambarkhane, ... Hematological Oncology 39, 2021 | | 2021 |
| Estimation of Long-Term Survival with Tafasitamab+ Lenalidomide in Relapsed/Refractory Diffuse Large B-Cell Lymphoma G Salles, B Goswami, V Bagnardi, D Dey, M Winderlich, S Ambarkhane, ... Blood 136, 9-10, 2020 | | 2020 |
| Causal prophylactic efficacy of ganaplacide (KAF156) in a controlled human malaria infection model JG Kublin, SC Murphy, J Maenza, AM Seilie, JP Jain, B Goswami, ... Clinical Infectious Diseases, 2020 | | 2020 |
| A PHASE 1 EVALUATION OF THE PHARMACOKINETIC-PHARMACODYNAMIC INTERACTION OF THE ANTIMALARIAL AGENTS KAF156 AND PIPERAQUINE FJ Leong, JP Jain, E Feng, B Goswami, DS Stein, C Winnips AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 97 (5), 4-4, 2017 | | 2017 |